Daxor Corporation Common StockDXR

Daxor Corporation (Nasdaq: DXR) is tackling healthcare's 'multi-billion-dollar silent crisis', the inability to precisely measure blood volume. This often results in suboptimal care, prolonged hospital stays, and increased readmissions for many high-cost medical conditions like heart failure and those requiring ICU care. With 50 years of experience and innovation, Daxor is proud to manufacture and distribute its patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic which offers unmatched, real-time, precise data via its rapid, hand-held, lab-based.

daxor.com